Companies:
49,999
Total Market Cap:
142468739042094.42
Mersana Therapeutics
NASDAQ: MRSN
Healthcare
Biotechnology
Global Rank
#32007
Country Rank
#4347
Market Cap
38.39 M
Price
0.308
Change (%)
4.38%
Volume
5.65 M
Mersana Therapeutics's latest marketcap:
38.39 M
As of 07/28/2025, Mersana Therapeutics's market capitalization has reached $38.39 M. According to our data, Mersana Therapeutics is the 32007th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 38.39 M |
| Revenue (ttm) | 34.01 M |
| Net Income (ttm) | -74,009,000 |
| Shares Out | 4.99 M |
| EPS (ttm) | -15.01 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 08/12/2025 |
Market Cap Chart
Data Updated: 07/28/2025
Mersana Therapeutics's yearly market capitalization.
Mersana Therapeutics has seen its market value drop from $373.8 M to $38.39 M since 2017, representing a total decrease of 89.73% and an annual compound decline rate (CAGR) of 25.94%.
| Date | Market Cap($) | Change (%) | Global Rank |
|---|---|---|---|
| 07/28/2025 | $38.39 M | -78.27% | 32007 |
| 12/31/2024 | $176.7 M | -36.85% | 19761 |
| 12/29/2023 | $279.8 M | -52.15% | 16864 |
| 12/30/2022 | $584.7 M | 30.72% | 11273 |
| 12/31/2021 | $447.3 M | -75.46% | 14047 |
| 12/31/2020 | $1.82 B | 564.25% | 5653 |
| 12/31/2019 | $274.4 M | 190.06% | n/a |
| 12/31/2018 | $94.6 M | -74.69% | n/a |
| 12/29/2017 | $373.8 M | n/a |
Company Profile
Mersana Therapeutics was founded in 2001 in United States.
The company went public on 06/28/2017
on the Nasdaq Stock Market.
With 102 employees, it focuses on Healthcare and aims to drive innovation in Biotechnology.
Frequently Asked Questions
-
What is Mersana Therapeutics's (MRSN) current market cap?As of 07/28/2025, Mersana Therapeutics (including the parent company, if applicable) has an estimated market capitalization of $38.39 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Mersana Therapeutics (MRSN) rank globally by market cap?Mersana Therapeutics global market capitalization ranking is approximately 32007 as of 07/28/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.